Malignant Gastric Neoplasm — Trials

Malignant Gastric Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,844 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 650
Recruiting: 353
Ph III recruiting: 49
Growth YoY: +15.1%
Industry share: 26%
Top sponsor: Fudan University
Termination share: 26.1%
Trials / 1,000 deaths: 59.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (232)

clinicaltrialsPublishedShowing 701–750 of 862 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05159440	First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer	active not recruiting	Phase 1	70	TORL Biotherapeutics, LLCINDUSTRY	2	Oct 22, 2024	clinicaltrials
NCT06653478	Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment	recruiting	—	3,000	Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER